Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Endosc. May 16, 2014; 6(5): 176-185
Published online May 16, 2014. doi: 10.4253/wjge.v6.i5.176
Figure 1
Figure 1 Ghrelin cell densities (A) and ghrelin immunoreactivity intensities (B) in the oxyntic mucosa of the stomach of controls and IBS-total, IBS-D, IBS-M and IBS-C patients. aP < 0.05, and dP < 0.01 vs controls. IBS: Irritable bowel syndrome; IBS-total: All patients with irritable bowel syndrome; IBS-D: Patients with diarrhea as the predominant syndrome; IBS-M: Patients with both diarrhea and constipation; IBS-C: Patients with constipation as the predominant syndrome.